These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8624256)

  • 41. [Measures against falsified drugs].
    Andersson JR; Bengtsson F
    Lakartidningen; 2010 Mar 31-Apr 13; 107(13-14):927. PubMed ID: 20437657
    [No Abstract]   [Full Text] [Related]  

  • 42. 3. Drug regulations in Switzerland and their application.
    Hippenmeier F
    Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448
    [No Abstract]   [Full Text] [Related]  

  • 43. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1982; 681():1-33. PubMed ID: 6817525
    [No Abstract]   [Full Text] [Related]  

  • 45. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. WHO tries to tackle problem of counterfeit medicines in Asia.
    Pincock S
    BMJ; 2003 Nov; 327(7424):1126. PubMed ID: 14615319
    [No Abstract]   [Full Text] [Related]  

  • 47. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 48. [A historical review on International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) and internationalization of Japan's new drugs development and regulation].
    Kurokawa T
    Yakushigaku Zasshi; 2014; 49(2):165-70. PubMed ID: 25799837
    [No Abstract]   [Full Text] [Related]  

  • 49. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Definition of the drug given in 1969 by a committee of WHO experts].
    Quevauviller A; Mabileau J; Vaille C
    Ann Pharm Fr; 1969 Jun; 27(6):403-9. PubMed ID: 5392371
    [No Abstract]   [Full Text] [Related]  

  • 51. Exempt preparations: Historical perspectives.
    Harris LS
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S48-51. PubMed ID: 16529881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceutical reference standards.
    Wallén O
    WHO Chron; 1972 Sep; 26(9):389-92. PubMed ID: 5076978
    [No Abstract]   [Full Text] [Related]  

  • 54. Counterfeits kill!
    Ghebrehiwet T
    Imprint; 2006; 53(3):40-4. PubMed ID: 16821529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. WHO Expert Committee on Biological Standardization. Forty-sixth Report.
    World Health Organ Tech Rep Ser; 1998; 872():i-vii, 1-90. PubMed ID: 9615608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Standardized allergen extracts in the United States.
    Slater JE
    Clin Allergy Immunol; 2004; 18():421-32. PubMed ID: 15042927
    [No Abstract]   [Full Text] [Related]  

  • 57. [The system of information concerning pharmaceuticals and its role in efficient using of medicines: opinion of medical specialists].
    Rostova NB; Kudriashova AI
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2016; 24(2):106-10. PubMed ID: 29553212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of essential drugs. Fourth report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1990; 796():1-60. PubMed ID: 2124016
    [No Abstract]   [Full Text] [Related]  

  • 60. Patterns and problems of drug introduction and control.
    Káldor A
    Int J Clin Pharmacol; 1973 Apr; 7(2):163-7. PubMed ID: 4731282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.